Establishment and characterization of a cisplatin-resistant cell line (IGSK-1) from a poorly differentiated gastric adenocarcinoma

被引:0
|
作者
Satoshi Ohi
Naoto Takahashi
Kouzou Ninomiya
Masako Nakajima
Hisashi Hashimoto
Toshiaki Tachibana
Katsuhiko Yanaga
Hiroshi Ishikawa
机构
[1] Jikei University school of Medicine,Department of Anatomy II
[2] Jikei University school of Medicine,Department of Surgery
来源
Human Cell | 2007年 / 20卷
关键词
cell line; cisplatin; gastric cell; gastrin or somatostatin secretion; poorly differentiated adenocarcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
We successfully established a spontaneously cisplatin-resistant tumor cell line (designated as IGSK-1) derived from original gastric carcinoma. The patient was a 75-year-old Japanese woman. The histopathological diagnosis was gastric poorly differentiated adenocarcinoma accompanied with metastatic foci in lymph nodes, pT3, N2 M0, stage IIIB. The IGSK-1 cells grew as adhesive and monolayered cultures on the bottom of dishes. The susceptibility of the IGSK-1 cells to anti-cancer drugs was examined using oxygen electrode apparatus (Daikin, Tsukuba, JPN), and the results suggested TXL was effective, and CDDP, CPT-11 and 5-FU were not effective. Gastrin and somatostatin secretions were confirmed by immunohistochemical staining and also radioimmunoassay. Immunohistochemistry and radioimmunoassay for serotonin suggested the IGSK-1 cells might incorporate serotonin from the growth media. Spontaneously cisplatin-resistant gastric carcinoma cell line secreted gastrin and somatostatin is very important material for chemotherapy.
引用
收藏
页码:15 / 22
页数:7
相关论文
共 50 条
  • [21] Establishment and Characterization of a New Cell Line from Enzootic Nasal Adenocarcinoma in Goats: ENA-1
    Li, Lingxu
    Tan, Weiye
    Wang, Zhen
    Guo, Wenqing
    Yang, Deji
    Yao, Dawei
    VETERINARY SCIENCES, 2024, 11 (06)
  • [22] Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant
    Chau, Q
    Stewart, DJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (03) : 193 - 202
  • [23] Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary
    Yamada, Takashi
    Kanda, Takayoshi
    Mori, Hiroshi
    Shimokawa, Kaname
    Kagawa, Mitsuo
    Shibayama, Yuro
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [24] Establishment and characterization of a new gastric cancer cell line, XGC-1
    Peng, Jigui
    Xu, Hao
    Cai, Jianchun
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [25] Establishment and characterization of a human gastric carcinoma cell line TMC-1
    Shyu, RY
    Jiang, SY
    Jong, YJ
    Cheng, KC
    Lin, CH
    Yu, JC
    Wu, MF
    Chang, TM
    CELLS TISSUES ORGANS, 2004, 177 (01) : 37 - 46
  • [26] Establishment and characterization of a new gastric cancer cell line, XGC-1
    Jigui Peng
    Hao Xu
    Jianchun Cai
    Cancer Cell International, 20
  • [27] Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1
    Ma J.
    Maliepaard M.
    Kolker H.J.
    Verweij J.
    Schellens J.H.M.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (3) : 186 - 192
  • [28] Establishment and characterization of EB virus-free normal B-lymphocyte and interleukin-6-producing poorly differentiated adenocarcinoma cell lines derived from gastric tumor tissue.
    Ohi S.
    Hashimoto H.
    Tachibana T.
    Tabei I.
    Nakajima M.
    Sato K.
    Yanaga K.
    Ishikawa H.
    Human Cell, 2005, 18 (1) : 35 - 44
  • [29] CHARACTERIZATION OF HIGH-LEVEL CISPLATIN-RESISTANT CELL-LINES ESTABLISHED FROM A HUMAN HEPATOMA-CELL LINE AND HUMAN KB ADENOCARCINOMA CELLS - CROSS-RESISTANCE AND PROTEIN-CHANGES
    SHEN, DW
    AKIYAMA, S
    SCHOENLEIN, P
    PASTAN, I
    GOTTESMAN, MM
    BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 676 - 683
  • [30] ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PRIMARY PROSTATIC ADENOCARCINOMA CELL-LINE (ND-1)
    NARAYAN, P
    DAHIYA, R
    JOURNAL OF UROLOGY, 1992, 148 (05) : 1600 - 1604